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PreviewsCertainly can’t live without this: SIRT6
Cellular metabolic rates might regulate aging by impinging on genomic stability through the DNA repair pathways. A new
study published in Cell (Mostoslavsky et al., 2006) reports that deficiency in one of the mammalian Sir2 homologs, SIRT6,
results in genome instability through the DNA base excision repair pathway and leads to aging-associated degenerative
phenotypes.Maintenance of genome integrity is a bio-
logical process that is crucial for organis-
mal longevity and cell survival. This is
very clearly demonstrated in the patho-
physiology of some progeroid diseases.
Progeroid diseases are heritable muta-
tions often in genes involved in repairing
and detecting damaged DNA. Progeroid
diseases are known to cause abnormali-
ties that are extremely pleiotropic, se-
vere, and progressive, but reminiscent
to that of normal aging (Hasty et al.,
2003). Some common symptoms include
lipodystrophy, kyphosis, neurodegener-
ation, immune deficiency, loss of hair,
osteoporosis, predisposition to cancer,
and metabolic defects. It is because pro-
geroid diseases cause the vastly acceler-
ated onset of symptoms similar to normal
aging that they can be used as model to
study human aging. A new report by
Mostoslavsky et al. (2006) identifies that
the relatively undescribed protein SIRT6
functions in DNA repair pathways. More-
over, they show that SIRT6 null mice dis-
play numerous progeroid and aging-like
phenotypes, providing a new and excit-
ing progeroid/aging model.
A decline in genomic stability might
provoke many of the adverse changes
seen in aging. Cells have designed DNA
repair systems that detect DNA damage
or respond to stress to maintain genome
integrity (Lombard et al., 2005). It is
thought that an important source of
DNA damage is production of reactive
oxygen species (ROS). ROS are byprod-
ucts of oxidative metabolism and lead to
activation of protective DNA repair path-
ways. In fact, one of the most discussed
theories of aging is cellular damage as-
sociated with ROS (Balaban et al.,
2005). Notably, calorie restriction (CR),
a unique dietary regimen capable of pro-
longing life span in different species, im-
pinges on pathways linked to ROS me-
tabolism and genomic integrity (Sohal
and Weindruch, 1996). In this respect,
strong genetic evidence from different
organisms including mammals has re-
vealed the insulin/IGF1 pathway to con-CELL METABOLISM 3, 77–82, FEBRUARY 200trol life span (Kenyon et al., 1993). Taken
together, it seems clear that there is
a connection between genomic stability,
metabolism, and aging.
A number of studies on yeast aging
have shown that genomic stability is
also crucial for their survival. This work
has focused on the protein Sir2 that was
first identified as a factor which regulated
the silent information at the yeast mating
type loci. Later, it was found that this pro-
tein was in a complex that coated telo-
meres and the rDNA repeats promoting
genomic stability. A major breakthrough
in this field came when it was discovered
that Sir2 is a NAD+-dependent deacety-
lase and is involved in life span extension
by CR in yeast (Figure 1) (Blander and
Guarente, 2004). In C. elegans, Sir2 also
promotes longevity in a Daf-16-depen-
dent manner (a forkhead transcription
factor repressed by the insulin/IGF1 sig-
naling) (Tissenbaum and Guarente,
2001). In mammals, there are seven Sir2
members called Sirtuins (SIRT1–SIRT7).
The past several years have brought sev-
eral excellent studies trying to identify
a link between Sirtuins, aging, and CR.
Much of the work centering on SIRT1,
the closest homolog of yeast Sir2, has
shown that it likely has roles in aging, reg-
ulating stress response, senescence,
and metabolism (Figure 1). However,
there has not yet been a mammalian
model constructed that clearly demon-
strates its role in aging. Sir2 null yeasts
are probably the closest semblance to
a unicellular progeroid model that exists
(premature aging, defects in DNA repair,
transcription, and recombination). Still
there is an unsolved question: Is there
a mammalian Sirtuin that functions in
a way similar to yeast Sir2?
A new report from Mostoslavsky et al.
(2006) might provide an answer to this
question. Their studies very clearly dem-
onstrate that SIRT6 prevents DNA dam-
age and maintains genomic stability in
murine cells. They generate SIRT6
knockout MEFs and ES cells and show
increased sensitivity to alkylating and ox-6 ª2006 ELSEVIER INC.idizing agents. This sensitivity is rescued
by overexpression of DNA Polb, indicat-
ing that SIRT6 may be involved in the
base excision repair (BER) pathway. A
crucial finding is that the SIRT6 enzy-
matic—possibly ADP-ribosylatransfer-
ase and/or protein deacetylase—is re-
quired for its effects on BER. The SIRT6
KO mice also develop a striking proge-
roid degenerative syndrome that in-
cludes lymphopenia, loss of subcutane-
ous fat, and lordokyphosis. Null mice
also display several metabolic defects in-
cluding very low levels of IGF-1 and are
highly hypoglycemic. These studies pro-
vide us with the first mammalianmodel of
aging that involves a Sirtuin.
Several very interesting questions arise.
What is SIRT6? An NAD+-dependent
ADP-ribosyltransferase or deacetylase?
Previous reports show that SIRT6 can
act as an ADP-ribosyltransferase (Liszt
et al., 2005). However, Mostoslavsky
et al. (2006) demonstrate that SIRT6 can
deacetylate histones and DNA polb
in vitro. This is extraordinarily interesting
because DNA Polb is repressed by acety-
lation in vivo (Hasan et al., 2002). There-
fore, it becomescritical to exploreSIRT6’s
enzymatic activity and identify substrates
to understand its mechanism of action in
both cell and organismal survival. As it re-
lates to therapeutics, the possibility to
modulate this enzymatic activity becomes
a very attractive target for drugs to pre-
vent age-associated diseases.
Defects in DNA repair pathways are
known to cause a number of progeroid
phenotypes. However, none have been
found in the BER pathway and null mice
for components of BER are either lethal
or have very little effect (Hasty et al.,
2003). In this regard, deficiency of
SIRT6 becomes the first example for
a protein involved in the BER pathway
that produces an aging-like progeroid
phenotype. This report provides also ev-
idence that SIRT6 is upstream of DNA
Polb, although how exactly SIRT6 func-
tions in BER is completely unknown and
becomes a new challenge for the future.77
P R E V I E W SFigure 1. Model for Sir2 and Sirtuins nutrient-regulated function on longevity
In yeast, Sir2 is in a complex that promotes transcriptional silencing and genomic stability and is involved in
the lifespan extension by CR. It is postulated that this is a function dependent on NAD+ and/or Nam (nicotin-
amide). Fluctuations of these metabolites induced by CR regulate Sir2 activity leading to increased genomic
stability and prolonged lifespan. In mammals, SIRT1 has shown that it too likely responds to NAD+ fluctuation
and modulates key transcription factors in stress response, senescence, and metabolism. However, currently,
SIRT1 has no clear role in genomic stability. Notably, SIRT6 is involved in DNA repair pathways and promotes
genomic stability and longevity. Might SIRT6 function similarly to yeast Sir2 promoting genomic stability in re-
sponse to nutrient signals?Possibly the most attractive model is
the ability of Sir2 and Sirtuin enzymes to
be activated by increases of NAD+ levels.
Sirtuins are likely to be sensors for fluctu-
ations of NAD+ in responses to nutrient
deprivation, insulin/IGF1 levels, or oxida-
tive stresses. Once activated, Sirtuins will
impinge on different biological processes
such as DNA repair systems, transcrip-
tional regulation, ormetabolic processes.
The fact that SIRT6 requires enzymatic
activity to function might suggest it is
a NAD+ sensor linking nutrient status to
genome stability. Prolonged life span by
caloric restriction has been associated
with changes in nutrient flux and meta-78bolic pathways. It is conceivable that
generation of signals from these path-
ways are sensed by Sirtuins to control
metabolic rates and to maintain DNA
repair systems as somatic cells age (Fig-
ure 1) (Cohen et al., 2004; Rodgers et al.,
2005). Future research to tackle essential
problems onSIRT6 function is an exciting
new route that will be taken. Howmecha-
nistically SIRT6 is involved in the BER
pathway? Is SIRT6 regulated by nutrient
or hormonal fluctuations? Is SIRT6 a criti-
cal component of the effects of CR on
lifespan? Certainly, new studies to pro-
vide answers to these questions will be
enlightening and may provide a strongerlink between metabolism, genomic sta-
bility, and aging.
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